Mark Leonard Singleton - 10 Apr 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Reporting relationship: SVP & CFO
Issuer ticker: BVS
Reported as of: 10 Apr 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Apr 2023, 21:14:53 UTC
Prior SEC filing: 27 Mar 2023
Next SEC filing: 22 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/Anthony D'Adamio, Attorney-in-Fact

Key filing fact

Mark Leonard Singleton filed Form 4 for Bioventus Inc. (BVS) on 12 Apr 2023.

Key facts

This page summarizes Mark Leonard Singleton's Form 4 filing for Bioventus Inc. (BVS).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 12 Apr 2023, 21:14.

Change

Previous filing in this sequence was filed on 27 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BVS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,581
Date: 10 Apr 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BVS transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +52,000
Change %
Price: $0.000000
Shares after: 52,000
Date: 10 Apr 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 52,000
Exercise price
Footnotes: F1, F2

BVS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +135,800
Change %
Price: $0.000000
Shares after: 135,800
Date: 10 Apr 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 135,800
Exercise price: $1.16
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

Footnote F2

The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.